In addition, targeting of drugs presents the advantage of lowering the effective dose thereby decreasing potential side effects. The technology offers the potential of delivery of therapeutic agents across the blood brain barrier. The technology targets neuropeptides or other pharmaceuticals to the central nervous system. The technology should also be useful in the treatment of neurodegenerative diseases, spinal cord injuries, and cerebral ischemia due to stroke. Patent Status On file with patent attorney.
Additional information is available under the terms of a confidentiality agreement .